Cataflam and Flatulence - a phase IV clinical study of FDA data

Summary:

Flatulence is reported as a side effect among people who take Cataflam (diclofenac potassium), especially for people who are female, 60+ old, also take Allegra, and have Peripheral neuropathy.

The phase IV clinical study analyzes which people have Flatulence when taking Cataflam. It is created by eHealthMe based on reports of 1,750 people who have side effects when taking Cataflam from the FDA, and is updated regularly.

What is Cataflam?

Cataflam has active ingredients of diclofenac potassium. It is often used in pain. eHealthMe is studying from 1,851 Cataflam users. Check the latest studies of Cataflam.

What is Flatulence?

Flatulence (flatus expelled through the anus) is found to be associated with 1,805 drugs and 1,884 conditions by eHealthMe. Check the latest studies of Flatulence.



On Jan, 23, 2026

1,750 people reported to have side effects when taking Cataflam.
Among them, 17 people (0.97%) have Flatulence.

Could Cataflam cause Flatulence?

Among these 17 people:

What is the gender of people who have Flatulence when taking Cataflam? *

  • female: 93.75 %
  • male: 6.25 %

What is the age of people who have Flatulence when taking Cataflam? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 16.67 %
  • 40-49: 25.0 %
  • 50-59: 16.67 %
  • 60+: 41.67 %

What are other drugs people take besides Cataflam? *

  1. Allegra: 5 people, 29.41%
  2. Vitamin E: 3 people, 17.65%
  3. Bentyl: 3 people, 17.65%
  4. Benadryl: 3 people, 17.65%
  5. Ambien: 3 people, 17.65%
  6. Vioxx: 2 people, 11.76%
  7. Norco: 2 people, 11.76%
  8. Feldene: 2 people, 11.76%
  9. Nasonex: 2 people, 11.76%
  10. Nasacort: 2 people, 11.76%

What are other side effects people have besides Flatulence? *

  1. Abdominal Distension: 4 people, 23.53%
  2. Abdominal Pain Upper: 4 people, 23.53%
  3. Constipation: 3 people, 17.65%
  4. Diarrhea: 3 people, 17.65%
  5. Nausea (feeling of having an urge to vomit): 3 people, 17.65%
  6. Malaise (a feeling of general discomfort or uneasiness): 2 people, 11.76%
  7. Itching: 2 people, 11.76%
  8. Belching (release of gas from the digestive tract): 2 people, 11.76%
  9. Bedridden: 2 people, 11.76%
  10. Dry Mouth: 2 people, 11.76%

What are the existing conditions these people have? *

  1. Peripheral Neuropathy (damage to nerves of the peripheral nervous system): 2 people, 11.76%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.88%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 5.88%
  4. Migraine (headache): 1 person, 5.88%
  5. Impaired Gastric Emptying: 1 person, 5.88%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.88%
  7. High Blood Pressure: 1 person, 5.88%
  8. Gastric Disorder (disease of stomach): 1 person, 5.88%
  9. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Cataflam and have Flatulence?

- Check whether Flatulence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cataflam:

Flatulence treatments and more:

How severe was Flatulence and when was it recovered:

Expand to all the drugs that have ingredients of diclofenac potassium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cataflam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Flatulence:

Browse all the conditions that are associated with Flatulence:

Drugs similar to Cataflam and Flatulence :


How the study uses the data?

The study uses data from the FDA. It is based on diclofenac potassium (the active ingredients of Cataflam) and Cataflam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent personalized studies on eHealthMe: